NICE only reviews a drug after it's been approved by MHRA. They don't have NHS subsidize drugs which are not approved by MHRA. So given NICE are already involved in determining if they will reimburse the cost of DCVax, I believe the firm are well ahead of what they disclosed at the 2022 ASM.
Bio, considering that J. Cofer Black is on the team and guiding NWBO through this maze of nefarious forces, I really doubt we can hang our hats on any kind of timeline or release of any pertinent information based on what was said at the ASM. The CIA’S modus operandi is based on controlling a situation to achieve the desired outcome. It will happen, when it happens and only a few at the top of the pyramid know when that will be. Thoughts?
Market Data 
Markets 
AI
